FDA approves Cambridge Archives

Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

Biotech Pharma

FDA Approves Cambridge Biotech’s First-Ever Drug for Cancer

January 17, 2020 3591 Views

Blueprint Medicines Corporation, a precision therapy company from Cambridge, Massachusetts, focused on genomically defined cancers, rare diseases and ...